Company Filing History:
Years Active: 2001-2015
Title: Anegondi Sreenivasa Prasad: Innovator in Pharmaceutical Chemistry
Introduction
Anegondi Sreenivasa Prasad is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex compounds. With a total of 3 patents to his name, Prasad's work has implications for treating various medical conditions.
Latest Patents
Prasad's latest patents include innovative processes for the preparation of Everolimus and its intermediates. This patent discloses methods for reacting Sirolimus (Rapamycin) under solvent-free conditions, utilizing portion-wise additions, one-pot conversions, and resin-mediated synthesis. Another significant patent involves a method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans. This method is particularly focused on creating 2,5-diaryl-substituted tetrahydrofurans and tetrahydrothiophenes. An important application of this invention is in the synthesis of CMI-392, a highly effective agent for treating inflammatory and immune disorders. The invention also encompasses novel compounds that serve as starting materials and intermediates in these synthetic processes.
Career Highlights
Throughout his career, Anegondi Sreenivasa Prasad has worked with prominent companies in the pharmaceutical industry, including Millennium Pharmaceuticals Limited and Biocon Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to drug synthesis.
Collaborations
Prasad has collaborated with notable professionals in his field, including Mukund Shankar Chorghade and Amin Ul Islam. These collaborations have further enhanced his research and development efforts in pharmaceutical chemistry.
Conclusion
Anegondi Sreenivasa Prasad is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His innovative patents and collaborations reflect his commitment to improving medical treatments and addressing health challenges.